Clinical Trial Update: Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer

View source ↗

Summary

This completed clinical trial assesses the role of Fluorine-18 PET/CT imaging for detecting bone metastases in prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Prostate Cancer | Status: COMPLETED